St. Jude Medical / Abbott: Portico™ Valve - (CE)
Transcatheter aortic valve devices
The Portico™ Transcatheter Aortic Heart Valve offers outstanding control and accuracy for optimal patient outcomes with low rates of post-procedure pacemaker implantations, complications and paravalvular leak (PVL). The valve’s unique delivery system provides controlled deployment for greater accuracy and precise placement. The Portico™ transcatheter aortic heart valve is part of St Jude Medical's transcatheter valve replacement portfolio.
Portico™ Valve introduction
The Portico™ transcatheter aortic heart valve is designed to be implanted in the native aortic heart valve without open-heart surgery and without concomitant surgical removal of the failed native valve. The valve is implanted using the Portico™ transfemoral delivery system.
Studies show that the Portico™ aortic valve has low rates of pacemaker implantation and complications and comparable PVL when compared to second-generation transcatheter aortic valve implantation (TAVI) valves.
Figure 63. Portico aortic valve
Figure 64. Portico aortic valve
Figure 65. Portico aortic valve
Portico™ Valve animation
Valve size (mm)
23 mm, 25 mm, 27 mm, 29 mm
Delivery system diameter - 1 [figure=66 chapter=3] / 2 [figure=67 chapter=3] / 3 [figure=68 chapter=3] / 4 [figure=69 chapter=3]
18 Fr [figure=70 chapter=3] for 23 mm and 27mm
Transfemoral [video=16 chapter=3], transapical, transaortic, subclavian
Retrievable after being fully deployed
Additional cuff to reduce AR
Tactile feedback during deployment
Large stent cell design
Markers to facilitate deployment
Motorised delivery system
CE mark status: 19/11/2012 (transfemoral)
- Low valve height allowing for sealing without the valve extending deep into the LVOT to minimise conduction interference
- The large cells in the annulus section of the stent are designed to minimise the risk of PV leak
- Leaflet geometry designed to function optimally in both round movie 17 [video=17 chapter=3] and elliptical configurations movie 26 [video=26 chapter=3]
- Transfemoral delivery system and 23 mm and 25 mm valve CE approved. Transapical, Transaortic and Subclavian systems and 27 mm, 29 mm are investigational devices. Not available for sale in the U.S.A.